Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses

Dhruvil R. Shah, Steve R. Martinez, Robert J Canter, Anthony D. Yang, Richard J Bold, Vijay P. Khatri

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background In the modern era of esophagectomy, we hypothesized that perioperative morbidity and mortality from cervical or thoracic sites of anastomoses would not be different. Methods We used the American College of Surgeons National Surgical Quality Improvement Program database to identify patients who underwent esophagectomy for lower esophageal or gastroesophageal (GE) junction malignancies from 2005 to 2010. Patients were categorized as having either a cervical or thoracic anastomosis based on CPT codes. Results There were 601 (66%) cervical and 308 (34%) thoracic anastomoses. Cervical anastomoses were associated with greater than 2 units of blood transfusion in a higher proportion of patients (10% vs. 3%, P = 0.001), and higher superficial surgical site infections (13% vs. 7%, P = 0.003). There were no difference in rates of organ/space infections (6% vs. 7%, P = 0.70), overall morbidity (38% vs. 39%, P = 0.84), or mortality (3% vs. 4%, P = 0.34). Median length of stay was similar (11.5 days cervical vs. 11 days thoracic, P = 0.89), even among patients with organ/space infections (18 days cervical vs. 21 days thoracic, P = 0.49). On multivariate analysis thoracic anastomosis was not a significant predictor of increased overall morbidity (OR 1.13: 95%CI 0.83-1.54). Conclusion After esophagectomy, the site of anastomosis does not predict an increased risk of perioperative morbidity or mortality. J. Surg. Oncol. 2013; 108:472-476.

Original languageEnglish (US)
Pages (from-to)472-476
Number of pages5
JournalJournal of Surgical Oncology
Volume108
Issue number7
DOIs
StatePublished - Dec 2013

Fingerprint

Thorax
Morbidity
Esophagectomy
Mortality
Current Procedural Terminology
Surgical Wound Infection
Esophagogastric Junction
Quality Improvement
Infection
Blood Transfusion
Length of Stay
Multivariate Analysis
Databases
Neoplasms

Keywords

  • cervical vs. thoracic
  • esophagectomy
  • morbidity
  • mortality
  • NSQIP

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. / Shah, Dhruvil R.; Martinez, Steve R.; Canter, Robert J; Yang, Anthony D.; Bold, Richard J; Khatri, Vijay P.

In: Journal of Surgical Oncology, Vol. 108, No. 7, 12.2013, p. 472-476.

Research output: Contribution to journalArticle

Shah, Dhruvil R. ; Martinez, Steve R. ; Canter, Robert J ; Yang, Anthony D. ; Bold, Richard J ; Khatri, Vijay P. / Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses. In: Journal of Surgical Oncology. 2013 ; Vol. 108, No. 7. pp. 472-476.
@article{4cf7ff049c754d3bbc288d196dfd8a02,
title = "Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses",
abstract = "Background In the modern era of esophagectomy, we hypothesized that perioperative morbidity and mortality from cervical or thoracic sites of anastomoses would not be different. Methods We used the American College of Surgeons National Surgical Quality Improvement Program database to identify patients who underwent esophagectomy for lower esophageal or gastroesophageal (GE) junction malignancies from 2005 to 2010. Patients were categorized as having either a cervical or thoracic anastomosis based on CPT codes. Results There were 601 (66{\%}) cervical and 308 (34{\%}) thoracic anastomoses. Cervical anastomoses were associated with greater than 2 units of blood transfusion in a higher proportion of patients (10{\%} vs. 3{\%}, P = 0.001), and higher superficial surgical site infections (13{\%} vs. 7{\%}, P = 0.003). There were no difference in rates of organ/space infections (6{\%} vs. 7{\%}, P = 0.70), overall morbidity (38{\%} vs. 39{\%}, P = 0.84), or mortality (3{\%} vs. 4{\%}, P = 0.34). Median length of stay was similar (11.5 days cervical vs. 11 days thoracic, P = 0.89), even among patients with organ/space infections (18 days cervical vs. 21 days thoracic, P = 0.49). On multivariate analysis thoracic anastomosis was not a significant predictor of increased overall morbidity (OR 1.13: 95{\%}CI 0.83-1.54). Conclusion After esophagectomy, the site of anastomosis does not predict an increased risk of perioperative morbidity or mortality. J. Surg. Oncol. 2013; 108:472-476.",
keywords = "cervical vs. thoracic, esophagectomy, morbidity, mortality, NSQIP",
author = "Shah, {Dhruvil R.} and Martinez, {Steve R.} and Canter, {Robert J} and Yang, {Anthony D.} and Bold, {Richard J} and Khatri, {Vijay P.}",
year = "2013",
month = "12",
doi = "10.1002/jso.23423",
language = "English (US)",
volume = "108",
pages = "472--476",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Comparative morbidity and mortality from cervical or thoracic esophageal anastomoses

AU - Shah, Dhruvil R.

AU - Martinez, Steve R.

AU - Canter, Robert J

AU - Yang, Anthony D.

AU - Bold, Richard J

AU - Khatri, Vijay P.

PY - 2013/12

Y1 - 2013/12

N2 - Background In the modern era of esophagectomy, we hypothesized that perioperative morbidity and mortality from cervical or thoracic sites of anastomoses would not be different. Methods We used the American College of Surgeons National Surgical Quality Improvement Program database to identify patients who underwent esophagectomy for lower esophageal or gastroesophageal (GE) junction malignancies from 2005 to 2010. Patients were categorized as having either a cervical or thoracic anastomosis based on CPT codes. Results There were 601 (66%) cervical and 308 (34%) thoracic anastomoses. Cervical anastomoses were associated with greater than 2 units of blood transfusion in a higher proportion of patients (10% vs. 3%, P = 0.001), and higher superficial surgical site infections (13% vs. 7%, P = 0.003). There were no difference in rates of organ/space infections (6% vs. 7%, P = 0.70), overall morbidity (38% vs. 39%, P = 0.84), or mortality (3% vs. 4%, P = 0.34). Median length of stay was similar (11.5 days cervical vs. 11 days thoracic, P = 0.89), even among patients with organ/space infections (18 days cervical vs. 21 days thoracic, P = 0.49). On multivariate analysis thoracic anastomosis was not a significant predictor of increased overall morbidity (OR 1.13: 95%CI 0.83-1.54). Conclusion After esophagectomy, the site of anastomosis does not predict an increased risk of perioperative morbidity or mortality. J. Surg. Oncol. 2013; 108:472-476.

AB - Background In the modern era of esophagectomy, we hypothesized that perioperative morbidity and mortality from cervical or thoracic sites of anastomoses would not be different. Methods We used the American College of Surgeons National Surgical Quality Improvement Program database to identify patients who underwent esophagectomy for lower esophageal or gastroesophageal (GE) junction malignancies from 2005 to 2010. Patients were categorized as having either a cervical or thoracic anastomosis based on CPT codes. Results There were 601 (66%) cervical and 308 (34%) thoracic anastomoses. Cervical anastomoses were associated with greater than 2 units of blood transfusion in a higher proportion of patients (10% vs. 3%, P = 0.001), and higher superficial surgical site infections (13% vs. 7%, P = 0.003). There were no difference in rates of organ/space infections (6% vs. 7%, P = 0.70), overall morbidity (38% vs. 39%, P = 0.84), or mortality (3% vs. 4%, P = 0.34). Median length of stay was similar (11.5 days cervical vs. 11 days thoracic, P = 0.89), even among patients with organ/space infections (18 days cervical vs. 21 days thoracic, P = 0.49). On multivariate analysis thoracic anastomosis was not a significant predictor of increased overall morbidity (OR 1.13: 95%CI 0.83-1.54). Conclusion After esophagectomy, the site of anastomosis does not predict an increased risk of perioperative morbidity or mortality. J. Surg. Oncol. 2013; 108:472-476.

KW - cervical vs. thoracic

KW - esophagectomy

KW - morbidity

KW - mortality

KW - NSQIP

UR - http://www.scopus.com/inward/record.url?scp=84887195243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887195243&partnerID=8YFLogxK

U2 - 10.1002/jso.23423

DO - 10.1002/jso.23423

M3 - Article

VL - 108

SP - 472

EP - 476

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 7

ER -